Which of the Following Is the Primary Goal of Pharmacological Management in Patients with Alzheimer’s Disease

Mrs. Santos, a 72-year-old Female, Has Been Diagnosed with Alzheimer’s Disease. She Is Currently in the Moderate Stage of the Disease and Is Experiencing Memory Loss, Confusion and Difficulty Performing Daily Activities. She Is Prescribed with a Cholinesterase Inhibitor as Part of Her Treatment